|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:CEO
|
gptkb:Ron_Cohen
|
|
gptkbp:employees
|
approximately 1,000
|
|
gptkbp:focus
|
vaccines
|
|
gptkbp:founded
|
1993
|
|
gptkbp:founder
|
gptkb:Jaap_Goudsmit
|
|
gptkbp:headquarters
|
gptkb:Leiden,_Netherlands
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Crucell
|
|
gptkbp:industry
|
biotechnology
pharmaceuticals
|
|
gptkbp:keyPeople
|
gptkb:Henk_de_Jong
gptkb:Johan_van_Hoof
gptkb:Jan_van_der_Meer
gptkb:Johan_van_der_Veen
gptkb:Henk_van_der_Veen
gptkb:Jaap_Goudsmit
gptkb:Hans_van_der_Meer
gptkb:Pieter_van_der_Meer
gptkb:Willem_van_der_Meer
gptkb:Ron_Cohen
gptkb:Kees_van_der_Meer
|
|
gptkbp:location
|
Leiden
|
|
gptkbp:notableEvent
|
AdVac technology
PER.C6 cell line
Quinvaxem
|
|
gptkbp:partnerships
|
gptkb:GlaxoSmithKline
gptkb:Merck_&_Co.
gptkb:Sanofi_Pasteur
|
|
gptkbp:products
|
gptkb:COVID-19_vaccine
Hepatitis B vaccine
HPV vaccine
Influenza vaccine
Meningococcal vaccine
Yellow fever vaccine
Ebola vaccine
Rabies vaccine
Typhoid vaccine
DTPaHibVIPVHB vaccine
|
|
gptkbp:researchFocus
|
monoclonal antibodies
viral vaccines
|
|
gptkbp:subsidiary
|
gptkb:Crucell_Switzerland_AG
gptkb:Crucell_Holland_B.V.
gptkb:Crucell_USA_Inc.
|
|
gptkbp:tradedOn
|
Euronext Amsterdam
|
|
gptkbp:type
|
public company
|
|
gptkbp:website
|
www.crucell.com
|